Product Usage

THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic.

GLP2-T 20MG

Originally developed for type 2 diabetes management, Tirzepatide has demonstrated additional benefits, including cardiovascular protection and effective weight loss support.

$320.00

Peptides will arrive in a lyophilized (powder) form for maximum stability

Buy 5 for 5% off
Buy 10 for 10% off
Buy 15 for 15% off

OVERVIEW

Originally developed for type 2 diabetes management, Tirzepatide has demonstrated additional benefits, including cardiovascular protection and effective weight loss support. This synthetic peptide is derived from gastric inhibitory polypeptide (GIP) while also acting as a glucagon-like peptide-1 (GLP-1) receptor agonist, allowing it to:

  • Regulate blood sugar levels
  • Enhance insulin sensitivity
  • Promote satiety
  • Facilitate weight loss

RESEARCH

Tirzepatide is a synthetic analogue of gastric inhibitory polypeptide (GIP), designed to stimulate insulin release and support the management of type 2 diabetes and non-alcoholic fatty liver disease. Composed of 39 amino acids, this peptide functions by activating both GIP and GLP-1 receptors, leading to improved insulin regulation and metabolic balance.

Long-term use of Tirzepatide has been shown to increase adiponectin levels by up to 26%, contributing to:

  • Reduced hunger and cravings
  • Lower fasting insulin levels
  • Greater insulin sensitivity

These metabolic effects result in:

  • Significant weight loss (approximately 11 kg or 25 lbs)
  • Enhanced glucose control
  • Decreased fat storage
  • Lower cardiovascular risk factors

STRUCTURE

  • Amino Acid Sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ AFVQWLIAGGPSSGAPPPS
    (Aib is a non-standard amino acid: H H-C(CH3)COOH)
  • Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
  • Molecular Weight: 4813.527 g/mol
  • PubChem Identifier: 156588324
  • CAS Registry Number: 2023788-19-2
  • Alternative Names: P1206, LY3298176

CITATIONS

Source: PubChem

 

OVERVIEW

Originally developed for type 2 diabetes management, Tirzepatide has demonstrated additional benefits, including cardiovascular protection and effective weight loss support. This synthetic peptide is derived from gastric inhibitory polypeptide (GIP) while also acting as a glucagon-like peptide-1 (GLP-1) receptor agonist, allowing it to:

  • Regulate blood sugar levels
  • Enhance insulin sensitivity
  • Promote satiety
  • Facilitate weight loss

RESEARCH

Tirzepatide is a synthetic analogue of gastric inhibitory polypeptide (GIP), designed to stimulate insulin release and support the management of type 2 diabetes and non-alcoholic fatty liver disease. Composed of 39 amino acids, this peptide functions by activating both GIP and GLP-1 receptors, leading to improved insulin regulation and metabolic balance.

Long-term use of Tirzepatide has been shown to increase adiponectin levels by up to 26%, contributing to:

  • Reduced hunger and cravings
  • Lower fasting insulin levels
  • Greater insulin sensitivity

These metabolic effects result in:

  • Significant weight loss (approximately 11 kg or 25 lbs)
  • Enhanced glucose control
  • Decreased fat storage
  • Lower cardiovascular risk factors

STRUCTURE

  • Amino Acid Sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ AFVQWLIAGGPSSGAPPPS
    (Aib is a non-standard amino acid: H H-C(CH3)COOH)
  • Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
  • Molecular Weight: 4813.527 g/mol
  • PubChem Identifier: 156588324
  • CAS Registry Number: 2023788-19-2
  • Alternative Names: P1206, LY3298176

CITATIONS

Source: PubChem

 

All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind.

The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.

Biogenesis Peptides is a chemical supplier. Biogenesis Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Biogenesis Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.